Joseph F. Rhoderick

Differentiation of substrate and non-substrate inhibitors of transport system xc−: an obligate exchanger of L-glutamate and L-cystine

Sarjubhai A. Patel, Brady A. Warren, Joseph F. Rhoderick et al. · Neuropharmacology · 2003 · 157 citations

Molecular Pharmacology, Biochemistry, Obligate Exchanger +9

Nγ-Aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site

C. Sean Esslinger, Kimberly A. Cybulski, Joseph F. Rhoderick · Bioorganic & Medicinal Chemistry · 2004 · 152 citations

Protein Chemistry, Molecular Pharmacology, Biochemistry +4

Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity and chronic lung disease following silica exposure

Forrest Jessop, Raymond F. Hamilton, Joseph F. Rhoderick et al. · Toxicology and Applied Pharmacology · 2016 · 103 citations · Full text

Inflammation, Cell Autophagy, Autophagy Deficiency +10

Phagolysosome acidification is required for silica and engineered nanoparticle-induced lysosome membrane permeabilization and resultant NLRP3 inflammasome activity

Forrest Jessop, Raymond F. Hamilton, Joseph F. Rhoderick et al. · Toxicology and Applied Pharmacology · 2017 · 91 citations

Extracellular Microvesicles, Membrane Biology, Nano-drug Delivery +8

The substituted aspartate analogue l-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3

C. Sean Esslinger, Shailesh R. Agarwal, John M. Gerdes et al. · Neuropharmacology · 2005 · 57 citations

Synaptic Plasticity, Molecular Neuroscience, Transporter Eaat3 +12